Markets for Advanced Wound Management Technologies

The global advanced wound management products market should reach $16.0 billion by 2026 from $11.9 billion in 2021 at a compound annual growth rate (CAGR) of 6.2% for the forecast period of 2021 to 2026.

Report Includes

• 31 data tables and 46 additional tables
• An updated review of the global market for advanced wound management (AWM) products and technologies
• Analyses of the global market trends, with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
• Highlights of key market dynamics (DROs) for advanced wound management products, regulatory scenario, and impact analysis of COVID-19 crisis on the growth of this market
• Estimation of the current market size and revenue forecast for AWM markets, and corresponding market share analysis by product type, end use, application and geographic region
• Discussion of market trends and industry structure with relate to advanced wound management, applications and business considerations of AWM products and technologies, and descriptions of relevant market forces
• Insight into the recent industry strategies, M&A deals of the major players operating within the global market; their key competitive landscape and company share analysis
• Review of selected new AWM products in development and emerging technologies, clinical trial applications, and potential markets for future developments
• Descriptive company profiles of the major market participants, including 3M, AbbVie Inc., Cardinal Health, Integra LifeSciences, Smith & Nephew PLC and Urgo Group

The global market for advanced wound management totaled $8.6 billion in 2013, up from 2011’s value of $7.9 billion. By 2018, this market is likely to reach $11.3 billion, a compound annual growth rate (CAGR) of 5.6%.

Report Includes

• An overview of the global markets for advanced wound care and related technologies.
• Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates (CAGRs) through 2018.
• Information on various products and segments in the market such as biological dressings, surgical sealants, synthetic dressings, anti–adhesion products and other related wound healing products and devices.
• Analyses of key strategies, competitive insights, and developments of key companies in the market.
• A look at how new technological products are competing in a fast track market that seeks to improve the quality of life for millions of individuals needing both acute and chronic wound care.

The total market for advanced wound care reached at $3.4 billion in 2010. It is expected to reach at $3.6 billion in 2011; it will further grow to $4.6 billion by 2016 at a compound annual growth rate (CAGR) of 4.9%.

• The U.S. market for advanced wound care will increase from $3.0 billion in 2007 to an estimated $3.5 billion by the end of 2008. It should reach $6.0 billion in 2013, a compound annual growth rate (CAGR) of 11.7%.
• Wound care dressings, sealants and anti-adhesion products have the largest share of the market, worth $1.7 billion in 2007. This is expected to increase to more than $1.8 billion in 2008 and more than $3.0 billion in 2013, for a CAGR of 10.0%.
• Wound healing devices have the second largest market share, generating $1.3 billion in 2007 and an estimated $1.6 billion in 2008. This should increase at a CAGR of 13.4% to reach $3.0 billion in 2013.

• The total U.S. market for advanced wound care technologies was worth more than $2.3 billion in 2005. By the end of 2006 the market will reach almost $2.6 billion, and over a five-year period will grow at an average annual growth rate (AAGR) of 12.3% to reach $4.6 billion in 2011.
• Wound care dressings, sealants, and antiadhesion products held the largest market share through the forecast period by a small margin, with 59.2% of the total market in 2006. By the end of 2011 the segment will hold 55% of the total U.S. market.
• Wound healing devices account for a smaller portion of revenues with nearly 1.1 billion in estimated sales for 2006 or 40.8% of revenues. Products in this segment include electrostimulation products, hyperbaric oxygen therapies, vacuum assisted therapies, and other products.

• The total U.S. market for advanced wound care was estimated at more than $1.7 billion in 2003 and is expected to rise at an AAGR (average annual growth rate) of 10.2% to $2.8 billion.
• Biological dressings, surgical sealants, synthetic dressings and other wound healing products account for $1.1 billion and will rise at an AAGR of 7.2%.
• Wound healing devices, e.g., electrostimulation products, hyperbaric oxygen therapies and vacuum-assisted therapies, account for a smaller portion with $608.2 million in sales but are rising faster at an AAGR of 15%.

• The total U.S. market for wound care products in 2000 exceeded $2.1 billion. Growing at an average annual rate (AAGR) of 10.1%, this market is forecast to exceed $3.4 billion in 2005.
• The market share for wound closing technologies will rise from 58.7% to over 63% in 2005, as this segment rises at an AAGR of 11.7%.
• At 34%, synthetic dressings represent the second largest market segment, but, growing at an AAGR of 7.1%, will drop to 30% in 2005.
• Biological and biosynthetic dressings will feature the fastest growth, rising at an AAGR of 14.2% during the period.